Find Clinical Trial
Efficacy of Detralex® in Edema Treatment. An open, 6-month, multicentre study. EDET Study
← Back
| Study Phase |
Phase 4 |
| Therapeutic Area |
Cardiovascular Diseases |
| Indication | venous disease |
| Sponsor | Servier s.r.o. |
| Active substance/ Medical device |
MICRONISED PURIFIED FLAVONOID FRACTION, |
| Active Substance Code | S005682 |
| Protocol Code | IC4-05682-099 |
| EudraCT Code | 2006-005721-28 |
Documents and links
| Scientific publication | READ MORE  |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility
